Ramipril Export Market Intelligence: India's 177 Suppliers Shipping to 93 Countries — TransData Nexus 2026

Q: Who are the top ramipril exporters from India?

The top ramipril exporters from India are: 1. MYLAN LABORATORIES LIMITED — $17.0M (18.9% market share); 2. GENO PHARMACEUTICALS PRIVATE LIMITED — $14.0M (15.6% market share); 3. AUROBINDO PHARMA LTD — $13.3M (14.8% market share); 4. SANOFI INDIA LIMITED — $6.5M (7.3% market share); 5. IND SWIFT LIMITED — $6.4M (7.1% market share). Together they account for 63.7% of India's total ramipril export value.

Q: What is the total export value of ramipril from India?

The total export value of ramipril from India is $89.8M USD, recorded across 4,977 shipment transactions from 177 active exporters to 93 destination countries. The average shipment value is $18.0K.

Q: Which countries import ramipril from India?

India exports ramipril to 93 countries worldwide. The top importing countries are: UNITED KINGDOM (35.0% share, $31.4M), FRANCE (23.2% share, $20.8M), UNITED STATES (14.4% share, $12.9M), CANADA (6.2% share, $5.6M), ITALY (4.9% share, $4.4M). These five markets account for 83.7% of total export value.

Q: What is the HS code for ramipril exports from India?

The primary HS code for ramipril exports from India is 30049071. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of ramipril exports from India?

The average unit price for ramipril exports from India is $13.25 USD per unit, with prices ranging from $0.00 to $1296.90 depending on formulation, packaging, and order volume. The total market is valued at $89.8M across 4,977 shipments.

Q: Which ports handle ramipril exports from India?

The primary ports for ramipril exports from India are NHAVA SHEVA SEA (INNSA1) (13.2% of shipments), JNPT/ NHAVA SHEVA SEA (11.1% of shipments), SAHAR AIR CARGO ACC (INBOM4) (6.1% of shipments), SAHAR AIR (5.8% of shipments), JNPT (5.4% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of ramipril?

India is one of the world's leading exporters of ramipril due to its large base of 177 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports ramipril to 93 countries, demonstrating 48% global market coverage.

Q: What certifications do Indian ramipril exporters need?

Indian ramipril exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import ramipril from India?

There are 389 registered buyers importing ramipril from India, spread across 93 countries. The repeat buyer rate is 72.5%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top ramipril supplier from India?

MYLAN LABORATORIES LIMITED is the leading ramipril exporter from India with a market share of 18.9% and total export value of $17.0M across 320 shipments. The top 5 suppliers together control 63.7% of total export value.

Suresh Sormare

Ramipril

India Pharmaceutical Trade Intelligence

$89.8M177 Suppliers93 CountriesHS 30049071

ExportsIndia → UNITED KINGDOM35.0%India → FRANCE23.2%

ImportsMALTA → India$520.7K GERMANY → India$469.4K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: CSP VIATRIS

Ramipril Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Ramipril to the World

Between 2022 and 2026, India exported $89.8M worth of ramipril across 4,977 verified shipments to 93 countries — covering 48% of world markets in the Cardiovascular segment. The largest destination is UNITED KINGDOM (35.0%). MYLAN LABORATORIES LIMITED leads with a 18.9% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30049071

Ramipril export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Ramipril export data snapshot — $89.8M · 177 exporters · 93 countriesTransData Nexus · Indian Customs Data

Top Ramipril Exporters from India

177 active exporters · Ranked by export value

View all 177 →

Top Ramipril Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MYLAN LABORATORIES LIMITED	$17.0M	320	5	18.9%
2	GENO PHARMACEUTICALS PRIVATE LIMITED

Top Countries Importing Ramipril from India

93 destination markets · Ranked by import value

All 93 countries →

Top Countries Importing Ramipril from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED KINGDOM	$31.4M	35.0%
2	FRANCE	$20.8M	23.2%
3	UNITED STATES	$12.9M	14.4%
4	CANADA	$5.6M	6.2%
5	ITALY	$4.4M	4.9%
6	TURKEY	$3.0M	3.3%
7	BELGIUM	$2.3M	2.5%
8	AUSTRALIA	$2.3M	2.5%
9	MALTA	$1.7M	1.9%
10	SPAIN	$1.2M	1.4%

UNITED KINGDOM is India's largest ramipril export destination, absorbing 35.0% of total exports worth $31.4M. The top 5 importing countries — UNITED KINGDOM, FRANCE, UNITED STATES, CANADA, ITALY — together account for 83.7% of India's total ramipril export value. The remaining 88 destination countries collectively receive the other 16.3%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Ramipril to India?

15 origin countries · Total import value: $1.1M

India imports ramipril from 15 countries with a combined import value of $1.1M. The largest supplier is MALTA ($520.7K, 11 shipments), followed by GERMANY and CANADA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Ramipril to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	MALTA	$520.7K	11	48.6%
2	GERMANY	$469.4K	62	43.9%
3	CANADA	$68.9K	121	6.4%
4	AUSTRIA	$3.3K	3	0.3%
5	UNITED STATES	$2.3K	2	0.2%
6	FRANCE	$1.6K	6	0.1%
7	UNITED KINGDOM	$1.2K	7	0.1%
8	BULGARIA	$849	8	0.1%
9	GUYANA	$692	2	0.1%
10	BELGIUM	$685	2	0.1%

Showing top 10 of 15 origin countries

MALTA is the largest supplier of ramipril to India, accounting for 48.6% of total import value. The top 5 origin countries — MALTA, GERMANY, CANADA, AUSTRIA, UNITED STATES — together supply 99.5% of India's ramipril imports. Click any country to see detailed supplier and buyer data for that import corridor.

Ramipril — Export Intelligence Video

Visual overview of India's ramipril import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's ramipril pharmaceutical import and export market — $89.8M in total trade, 177 verified manufacturers, and 93 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Ramipril

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Ramipril, an angiotensin-converting enzyme (ACE) inhibitor, has been widely approved in the United States through Abbreviated New Drug Applications (ANDAs). The FDA's Orange Book lists multiple approved ANDAs for ramipril, indicating a well-established generic market. Notably, the brand-name version, Altace, received its initial FDA approval on January 28, 1991, but all formulations have since been discontinued.

The absence of active import alerts or significant regulatory actions against ramipril underscores its compliance with FDA standards. Given that 177 Indian exporters have been active in the ramipril market, it is imperative for these entities to maintain rigorous adherence to FDA regulations to ensure continued market access.

2EU & UK Regulatory Framework

In the European Union, ramipril is subject to the European Medicines Agency's (EMA) marketing authorization process. A notable development occurred in December 2022 when the EMA recommended the authorization of Rambis, a combination of ramipril and bisoprolol, highlighting the agency's ongoing evaluation of ramipril-containing products. (ema.europa.eu)

In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) oversees ramipril's approval and monitoring. Recently, in March 2026, the MHRA issued a Class 2 Medicines Recall for a batch of Ramipril 5 mg Capsules due to a potential manufacturing error, emphasizing the importance of stringent quality control measures. (gov.uk)

Compliance with EU Good Manufacturing Practice (GMP) requirements is mandatory for all manufacturers supplying ramipril to these markets, ensuring product quality and patient safety.

3WHO Essential Medicines & Global Standards

Ramipril is included in the World Health Organization's (WHO) Model List of Essential Medicines, with the 24th edition published in September 2025. (who.int) This inclusion underscores its critical role in managing cardiovascular conditions globally. Manufacturers must ensure that ramipril formulations meet the standards set forth in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), to guarantee consistent quality across different markets.

4India Regulatory Classification

In India, ramipril is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates its pricing to ensure affordability. For instance, the ceiling price for ramipril was revised in July 2025, reflecting the government's commitment to making essential medicines accessible. Exporters are required to obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) before exporting ramipril, ensuring compliance with national regulations.

5Patent & Exclusivity Status

The primary patent for ramipril expired on October 29, 2008. Prior to this, in September 2007, the United States Court of Appeals for the Federal Circuit invalidated Aventis's patent on ramipril due to "obviousness," paving the way for generic competition. Consequently, the market has seen a proliferation of generic versions, intensifying competition and influencing pricing strategies.

6Recent Industry Developments

In March 2026, the UK's MHRA issued a Class 2 Medicines Recall for a batch of Ramipril 5 mg Capsules produced by Crescent Pharma Limited, citing potential manufacturing errors. (gov.uk) This incident highlights the critical importance of stringent quality control measures in pharmaceutical manufacturing.

In December 2022, the EMA recommended the authorization of Rambis, a combination of ramipril and bisoprolol, for use in the EU. (ema.europa.eu) This development reflects the agency's ongoing evaluation and approval of combination therapies involving ramipril, potentially expanding its therapeutic applications.

These developments underscore the dynamic nature of the pharmaceutical industry and the necessity for manufacturers and exporters to stay abreast of regulatory changes and quality standards to maintain market access and ensure patient safety.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Ramipril

Retail & reference prices across 9 markets vs. India FOB export price of $13.25/unit

Global Price Benchmark for Ramipril across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	N/A	USD	The U.S. Food and Drug Administration (FDA) does not regulate drug prices; therefore, official government pricing data for Ramipril is not available.
United Kingdom	N/A	GBP	The UK's National Health Service (NHS) Drug Tariff provides reimbursement prices for medications; however, specific pricing for Ramipril 5 mg tablets is not detailed in the available public data.
Germany	N/A	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) oversees drug approvals, but specific pricing information for Ramipril 5 mg tablets is not publicly disclosed.

Supply Chain Risk Assessment — Ramipril

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Ramipril, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. This dependency exposes the supply chain to vulnerabilities stemming from geopolitical tensions, trade restrictions, and disruptions in Chinese manufacturing. Despite initiatives like the Production Linked Incentive (PLI) scheme launched in 2020 to bolster domestic API production, progress has been gradual. As of February 2024, the Indian pharmaceutical sector continues to import a significant portion of its APIs and KSMs from China, underscoring the persistent reliance on external sources.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data from 2022 to 2026 indicates that the top five exporters of Ramipril from India account for 63.7% of the total export value, with MYLAN LABORATORIES LIMITED leading at 18.9%. This high supplier concentration poses a risk, as disruptions affecting these key players could significantly impact the global supply of Ramipril. While the PLI scheme aims to diversify and strengthen the supplier base, its full impact on reducing single-source dependency remains to be seen.

3Geopolitical & Shipping Disruptions

Access Complete Ramipril Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 4,977 transactions across 93 markets.

Request Demo View Pricing

Frequently Asked Questions — Ramipril Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top ramipril exporters from India?

The leading ramipril exporters from India are MYLAN LABORATORIES LIMITED, GENO PHARMACEUTICALS PRIVATE LIMITED, AUROBINDO PHARMA LTD, and 12 others. MYLAN LABORATORIES LIMITED leads with 18.9% market share ($17.0M). The top 5 suppliers together control 63.7% of total export value.

What is the total export value of ramipril from India?

The total export value of ramipril from India is $89.8M, recorded across 4,977 shipments from 177 active exporters to 93 countries. The average shipment value is $18.0K.

Which countries import ramipril from India?

India exports ramipril to 93 countries. The top importing countries are UNITED KINGDOM (35.0%), FRANCE (23.2%), UNITED STATES (14.4%), CANADA (6.2%), ITALY (4.9%), which together account for 83.7% of total export value.

What is the HS code for ramipril exports from India?

The primary HS code for ramipril exports from India is 30049071. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Ramipril

Ramipril

Top Ramipril Exporters from India

Top Countries Importing Ramipril from India

Who Supplies Ramipril to India?

Quick Facts

Related Cardiovascular

Related Analysis

Need Details?

Ramipril — Export Intelligence Video

Regulatory Landscape — Ramipril

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Ramipril

Supply Chain Risk Assessment — Ramipril

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

3Geopolitical & Shipping Disruptions

Access Complete Ramipril Trade Intelligence

Frequently Asked Questions — Ramipril Exports from India

Who are the top ramipril exporters from India?

What is the total export value of ramipril from India?

Which countries import ramipril from India?

What is the HS code for ramipril exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

4Risk Mitigation Recommendations

What is the average price of ramipril exports from India?

Which ports handle ramipril exports from India?

Why is India a leading exporter of ramipril?

What certifications do Indian ramipril exporters need?

How many buyers import ramipril from India?

What is the market share of the top ramipril exporter from India?

Analysis Methodology